Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Cancer/Oncology Drugs Market Witnessing Growth Spurts: Forecast to Grow at a CAGR of 9.5% by 2028: Zion Market Research

This image opens in the lightbox

News provided by

Zion Market Research

22 Feb, 2022, 11:34 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, Feb. 22, 2022 /PRNewswire/ --  As per analysts at Zion Market Research, the global cancer drugs market was capitalized at almost USD 155.12 Billion in 2020 and is anticipated to create income of almost USD 292.80 Billion by 2028, developing at a CAGR of almost 9.5% from 2021 to 2028.

Read Market Research Report "Cancer Drugs Market By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others), By Cancer Type (For Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other): Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2028."

The cancer drugs market has undergone a fall due to the various shutdowns and government orders as a view to contain the spread of COVID 19. The entire pharmaceutical industry was on a halt during stringent lockdown as all the attention shifted drastically on COVID 19. The restrictions imposed by various nations to contain COVID had stopped the supply chains and exchange of significant medical ingredients across countries, causing a downfall in the market. The pharmaceutical industry has now shifted all the investment, research to the focus of COVID19. Cancer industry Chemotherapy depends on the spending having made on R&D, but post pandemic, the spending has shifted for COVID.

Growing Research and Development On Targeted & Biological Drug Treatments For The Cure Of Cancer To Have Positive Effect On Cancer Drugs Market:

"Global cancer drugs market is majorly boosted by increasing cases of target disease such as breast cancer, lung cancer, and cervical cancer all over the globe," as per analysts at Zion Market Research. Other major boosting factors are growing research and development on targeted & biological drug treatments for the cure of cancer. On the other hand, stringent regulatory policies and the high cost of drug development paired along with the potential of failure are the primary limitations that might hinder the development of the cancer drugs market.

Nevertheless, huge spending in anti-cancer drugs research paired with rising aim on personalized medicine all over the world is likely to disclose the new growth opportunities for cancer drugs market in the years to come. Rising elderly population in developed as well as developing nation is also one of the major reasons responsible for the development of cancer drugs market. In addition, various mergers and acquisitions by market players are also set to bolster the cancer drugs market. For example, in June 2018, Bayer successfully concluded the acquirement of Monsanto. Similarly, in May 2018, Boehringer Ingelheim (the second biggest animal health firm in the world) boosted its investment in China by extending the Asian Veterinary R&D (Research & Development) hub to improve its innovation and research capacity.

Get More Insight before Buying @: https://www.zionmarketresearch.com/inquiry/cancer-drugs-market

North America Likely To Stay The Dominating Area In The Global Cancer Drugs Market In The Years To Come:

Europe, North America, Latin America, Asia-Pacific, and the Middle East & Africa are major regional sections in the global cancer drugs market. North America is likely to stay the dominating area in the years to come. Requirement for cancer drugs was uppermost in North America particularly in the U.S. Therefore, Asia Pacific is likely to be the moderate developing area in cancer drugs market in the years to come. In addition to this, the Latin America and Middle East & Africa are also likely to display moderate development for cancer drugs market in the coming years.

Report Scope:

Report Attribute

Details

Market size value in 2020

USD 155.12 Billion

Revenue forecast in 2028

USD 292.80 Billion

Growth Rate

CAGR of almost 9.5% 2021-2028

Base Year

2021

Historic Years

2016 - 2020

Forecast Years

2021 - 2028

Segments Covered

By Product Type, By Application, and By End Use

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2021 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

GlaxoSmithKline, Bayer, Sanofi, Novartis, Amgen, Pfizer, Bristol-Myers Squibb, Merck, Ariad Pharmaceuticals, Celgene Corporation, Hoffmann-La Roche Ltd, Eli Lilly, Johnson and Johnson, Boehringer Ingelheim GmbH, and Teva Pharmaceuticals among others

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail customized purchase options to meet your exact research needs.  

https://www.zionmarketresearch.com/buynow/su/cancer-drugs-market

Request Pre and Post COVID-19 Impact Analysis on Businesses: https://www.zionmarketresearch.com/custom/490?covid19=true

The Cancer Drugs Market is segmented as follows:

Cancer Drugs Market: By Cancer Therapy Outlook (2021-2028)

  • Immunotherapy
  • Targeted Therapy
  • Chemotherapy
  • Hormone therapy

Cancer Drugs Market: By Cancer Type Outlook (2021-2028)

  • Breast Cancer
  • Blood Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Skin Cancer
  • Lung Cancer

Cancer Drugs Market: By Region Outlook (2021-2028)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Get Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/cancer-drugs-market

List of Key Players of Cancer Drugs Market:

  • GlaxoSmithKline
  • Bayer
  • Sanofi
  • Novartis
  • Amgen
  • Pfizer
  • Bristol-Myers Squibb
  • Merck
  • Ariad Pharmaceuticals
  • Celgene Corporation
  • Hoffmann-La Roche Ltd
  • Eli Lilly
  • Johnson and Johnson
  • Boehringer Ingelheim GmbH
  • Teva Pharmaceuticals
  • others

Press Release For Cancer Drugs Market: https://www.zionmarketresearch.com/news/global-cancer-drugs-market

Browse Other Related Research Reports from Zion Market Research

  • Healthcare Contract Development and Manufacturing Organization Market: The global Healthcare Contract Development and Manufacturing Organization Market accrued earnings worth approximately 207.2 (USD Billion) in 2020 and is predicted to gain revenue of about 390.1 (USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028.
  • Stem Cell Therapy Market: The global Stem Cell Therapy Market accrued earnings worth approximately 182 (USD Million) in 2020 and is predicted to gain revenue of about 800 (USD Million) by 2028, is set to record a CAGR of nearly 20.1% over the period from 2021 to 2028
  • Immuno-Oncology Clinical Trials Market: The global Immuno-Oncology Clinical Trials Market accrued earnings worth approximately 5.4 (USD Billion) in 2020 and is predicted to gain revenue of about 15.6 (USD Billion) by 2028, is set to record a CAGR of nearly 13.7% over the period from 2021 to 2028.

Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/cancer-drugs-market

Browse through Zion Market Research's coverage of the Global Healthcare Industry

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research 
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com 
Website: https://www.zionmarketresearch.com/ 
Blog - https://zmrblog.com/

Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.